Table I.
IC50 value | |||
---|---|---|---|
Drug | Tca8113/ut | Tca8113/CBPTca8113/PYM | |
CBP (µg/ml) | 6.99±0.34 | 22.63±0.15a | 28.02±0.17b,c |
PYM (µg/ml) | 1.19±0.27 | 15.29±0.26a | 14.16±0.08b,c |
Paclitaxel (nM) | 1.07±0.14 | 6.35±0.24a | 4.69±0.11b,c |
Doxorubicin (µg/ml) | 3.54±0.13 | 4.48±0.19a | 5.45±0.23b,c |
P<0.05 vs. Tca8113/ut
P<0.05 vs. Tca8113/ut
P<0.05 vs. Tca8113/CBP. Data are presented as the mean ± standard deviation of three independent experiments for each cell line. IC50, 50% inhibiting concentration; ut, untreated; CBP, carboplatin; PYM, pingyangmycin.